| 1 |
34980594 | DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy. | 2022 Apr 1 |
1 |
| 2 |
33673439 | The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. | 2021 Feb 27 |
1 |
| 3 |
34066270 | The Protective Effects of EMF-LTE against DNA Double-Strand Break Damage In Vitro and In Vivo. | 2021 May 12 |
1 |
| 4 |
34108527 | DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia. | 2021 Jun 9 |
2 |
| 5 |
32196468 | Coupling of cell fate selection model enhances DNA damage response and may underlie BE phenomenon. | 2020 Apr |
2 |
| 6 |
32638521 | BReast CAncer susceptibility gene 2 deficiency exacerbates oxidized LDL-induced DNA damage and endothelial apoptosis. | 2020 Jul |
1 |
| 7 |
27655732 | A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining. | 2016 Sep |
1 |
| 8 |
26363031 | Mutagenic, surviving and tumorigenic effects of follicular fluid in the context of p53 loss: initiation of fimbria carcinogenesis. | 2015 Nov |
1 |
| 9 |
21674128 | DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status. | 2011 Sep |
1 |
| 10 |
17704360 | DNA repair after irradiation in glioma cells and normal human astrocytes. | 2007 Oct |
1 |
| 11 |
18089819 | Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks. | 2007 Dec 15 |
1 |